文献速递精神分裂症与精神病性障碍

易位蛋白作为精神分裂症神经炎症标记物的转化评估

Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.
PubMed 文献 · Mol Psychiatry · 2017-01-17

该研究结合神经发育与神经退行性小鼠模型及近期起病精神分裂症患者PET成像,评估TSPO作为神经炎症标记物的有效性。结果显示感染介导的神经发育模型中小鼠前额叶TSPO水平降低,而急性神经退行性模型中小鼠TSPO明显上调;患者中脑额中回TSPO结合呈降低趋势。研究提示精神分裂症的低度中枢炎症未必反映为TSPO表达或配体结合增加。

要点

  • 感染介导神经发育模型小鼠前额叶TSPO降低,伴行为异常和炎性细胞因子表达增加。
  • 急性神经退行性模型小鼠TSPO明显上调,且变化见于小胶质细胞、星形胶质细胞和血管内皮细胞。
  • 近期起病精神分裂症患者脑额中回TSPO结合呈降低趋势,挑战TSPO反映低度炎症的假设。

核心结论

  • 精神分裂症中的中枢低度炎症未必伴随TSPO表达或配体结合增加,解读TSPO改变需谨慎。

研究设计与样本

  • 采用转化方法,结合神经发育和神经退行性小鼠模型与近期起病精神分裂症患者及匹配对照的PET成像。

主要发现

  • 感染介导神经发育模型小鼠中,精神分裂症相关行为异常和炎性细胞因子表达增加与前额叶TSPO水平降低相关。
  • 海马内注射红藻氨酸诱导的急性神经退行性模型小鼠中,TSPO明显上调。
  • 两种模型中TSPO水平变化不限于小胶质细胞,还见于星形胶质细胞和血管内皮细胞。
  • 使用第二代TSPO放射性示踪剂[11C]DPA-713的人体PET成像显示,近期起病精神分裂症患者脑额中回TSPO结合呈强烈降低趋势。

临床怎么用

  • 精神分裂症中TSPO结合改变应谨慎解读,尤其当TSPO测量未结合其他炎症标记物时。
  • 在缺乏稳健反应性胶质增生的精神疾病中,细胞因子及其他炎症生物标志物连同其分子信号通路可能更准确刻画炎症特征。

局限性

  • 需更选择性小胶质细胞PET标记物可用后,才能更准确评估精神分裂症等疾病中的炎症特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Positron emission tomography (PET) imaging with radiotracers that target translocator protein 18 kDa (TSPO) has become a popular approach to assess putative neuroinflammatory processes and associated microglia activation in psychotic illnesses. It remains unclear, however, whether TSPO imaging can accurately capture low-grade inflammatory processes such as those present in schizophrenia and related disorders. Therefore, we evaluated the validity of TSPO as a disease-relevant marker of inflammation using a translational approach, which combined neurodevelopmental and neurodegenerative mouse models with PET imaging in patients with recent-onset schizophrenia and matched controls. Using an infection-mediated neurodevelopmental mouse model, we show that schizophrenia-relevant behavioral abnormalities and increased inflammatory cytokine expression are associated with reduced prefrontal TSPO levels. On the other hand, TSPO was markedly upregulated in a mouse model of acute neurodegeneration and reactive gliosis, which was induced by intrahippocampal injection of kainic acid. In both models, the changes in TSPO levels were not restricted to microglia but emerged in various cell types, including microglia, astrocytes and vascular endothelial cells. Human PET imaging using the second-generation TSPO radiotracer [11C]DPA-713 revealed a strong trend towards reduced TSPO binding in the middle frontal gyrus of patients with recent-onset schizophrenia, who were previously shown to display increased levels of inflammatory cytokines in peripheral and central tissues. Together, our findings challenge the common assumption that central low-grade inflammation in schizophrenia is mirrored by increased TSPO expression or ligand binding. Our study further underscores the need to interpret altered TSPO binding in schizophrenia with caution, especially when measures of TSPO are not complemented with other markers of inflammation. Unless more selective microglial markers are available for PET imaging, quantification of cytokines and other inflammatory biomarkers, along with their molecular signaling pathways, may be more accurate in attempts to characterize inflammatory profiles in schizophrenia and other mental disorders that lack robust reactive gliosis.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Notter T, Coughlin JM, Gschwind T, et al. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Mol Psychiatry. 2017. PMID: 28093569. doi:10.1038/mp.2016.248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。